PRESCRIBE AUSTRALIA
Prescribe Australia is a healthcare center that provides injury management, ergonomics, manual handling, and health solutions.
PRESCRIBE AUSTRALIA
Industry:
Health Care Rehabilitation Training
Founded:
2011-01-01
Address:
Wollongong, New South Wales, Australia
Country:
Australia
Website Url:
http://www.prescribeaustralia.com.au
Total Employee:
11+
Status:
Active
Contact:
+61 1300798771
Email Addresses:
[email protected]
Similar Organizations
Allsports Physiotherapy
Allsports Physiotherapy is a wellness center that provides injury management and rehabilitation services.
Beleura Health Solutions
Beleura Health Solutions is a rehabilitation and physiotherapy center that provides myotherapy, training, and massage services.
Frame Work Group
A workplace rehabilitation provider that offers Workplace Injury Management, Pre-employment Assessment, Education & Training solutions.
Current Employees Featured
Official Site Inspections
http://www.prescribeaustralia.com.au Semrush global rank: 8.12 M Semrush visits lastest month: 646
- Host name: 114.102.0.101.static.digitalpacific.com.au
- IP address: 101.0.102.114
- Location: Sydney Australia
- Latitude: -33.8591
- Longitude: 151.2002
- Timezone: Australia/Sydney
- Postal: 2000
More informations about "Prescribe Australia"
Myasthenia Gravis: Which Test Is Best? When and Why?
Jun 22, 2023 Drs Nicholas Silvestri and Carolina Barnett-Tapia discuss what you need to know about immunopathogenesis and diagnosis for this relatively rare condition.See details»
AAN 2025: Key Highlights of Advances in Myasthenia Gravis
Apr 15, 2025 Dr Nicholas Silvestri reports that the 2025 AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics and emerging therapies.See details»
New Steroid Dosing Regimen for Myasthenia Gravis - Medscape
Feb 16, 2021 Myasthenia gravis is a disorder of neuromuscular transmission, resulting from autoantibodies to components of the neuromuscular junction, most commonly the …See details»
Highlights in Myasthenia Gravis From AAN 2025 - Medscape
Apr 30, 2025 Highlights in myasthenia gravis from AAN 2025 include trials of new therapy inebilizumab, new data on the approved rozanolixizumab for ocular symptoms, and insights …See details»
US Incidence, Prevalence of Myasthenia Gravis Rising - Medscape
May 2, 2023 The incidence and prevalence of myasthenia gravis have increased in the United States, likely due to increased diagnosis and more awareness of the disease over time.See details»
AAN 2025: Anticipating New Approaches in Myasthenia Gravis
Mar 25, 2025 Dr Nicholas Silvestri looks ahead to new data on existing agents and emerging therapies for myasthenia gravis.See details»